For the many affected by chronic skin conditions such as atopic dermatitis and acne, the toll these conditions can take on them and their families is immeasurable.
With an extensive brands portfolio, Menarini Asia-Pacific markets a wide range of branded pharmaceutical, biotechnology, medical device and consumer health brands across key markets in Asia-Pacific. Building on our strengths in Dermatology, Select Specialty Care, Consumer Health, where we have experienced impressive success in these therapeutic fields, Menarini Asia-Pacific is now extending its offerings to include the following therapeutic fields: Men's Health, Cardiovascular and Allergy / Respiratory.
- Bilaxten®/ Labixten® Bilaxten/Labixten is a new non-sedating second generation antihistamine effective for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria. Bilaxten/Labixten offers a proven combination of high efficacy with a good safety and tolerability profile.